Who are the Top People in Radiology 2016?
Diagnostic Imaging’s annual Top People in Radiology contest is getting a new spin. This year, the contest will feature two categories: Rising Star and Lifetime Achievement.
Entrants must be U.S.-based and currently employed by or working in the radiology profession, including but not limited to physician, nurse, administrator, technologist, or researcher. Other applicable titles within the profession will also be considered.
Rising Stars must have begun practicing in the radiology profession in the last 10 years.
Lifetime Achievement nominees must be a 30+ year veteran of the radiology profession.
All nominees should exhibit outstanding potential or contribution to the field.[[{"type":"media","view_mode":"media_crop","fid":"52261","attributes":{"alt":"Top People in Radiology 2016","class":"media-image media-image-right","id":"media_crop_9104135537735","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"6491","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right; height: 93px; width: 100px; border-width: 0px; border-style: solid; margin: 1px;","title":" ","typeof":"foaf:Image"}}]]
Nominations must be made via SurveyMonkey submission.
Readers who nominate someone will be entered to win a drawing for a $100 gift card. Winners will be selected by committee made up of Diagnostic Imaging editorial board members.
Contest rules are available here.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.